C4 Share Price

C4 Share Price

NASDAQ: CCCC | Micro Cap | Healthcare
$2.48
+$0.06 (2.48%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

C4 Stock Performance

Open
$2.35
Prev. Close
$2.42
Circuit Range
N/A
Day Range
$2.35 - $2.54
Year Range
$1.70 - $5.17
Volume
2,38,601
Average Traded
$2.47

C4 Share Price Today

As of 21 November 2026, C4 Therapeutics, Inc.'s share price is $2.48. The stock opened at $2.35, compared to its previous close of $2.42. During today's trading session, C4 Therapeutics, Inc.'s share price traded between $2.35 and $2.54, with an average price of $2.44. Over the past 52 weeks, the stock has recorded a high of $5.17 and a low of $1.70. In terms of performance, C4 Therapeutics, Inc.'s share price has declined by 43.51% over the last six months and is down 8.15% on a year-on-year basis.

C4 Share Price Chart

Line chart of the C4 price trend over the selected period. The price rose overall, ranging from 2.35 to 2.54, ending at 2.48.
$2.35$2.54
L
Show Current Price
H

C4 Stock Fundamentals & Key Indicators

Market Cap
$205.58M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.69
Revenue (TTM)
$35.95B
Return On Equity (TTM)
-39.92%
Profit Margin
-292.04%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-6.59%

C4 Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$11.02$6.15$6.64$8.47
Net Profit-$20.49-$25.13-$23.64-$21.84
Net Profit Margin-185.93%-408.62%-356.02%-257.85%
Income ChangeN/A-22.65%5.93%7.61%

C4 Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$31.10$20.76$35.58$35.95
Net Profit-$128.18-$132.49-$105.32-$104.99
Net Profit Margin-412.15%-638.20%-296.01%-292.04%
Income ChangeN/A-3.36%20.51%0.31%

C4 Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets100.9791.84105.26143.28
Current Assets258.11257.77271.19287.56
Total Assets359.08349.6376.45430.84
Non Current Liabilities69.4688.4487.5797.06
Current Liabilities33.0345.1842.7744.55
Total Liabilities102.49133.62130.34141.61
Shareholders' Equity256.59215.99246.11289.23

C4 Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-98.69-65.16-106.84-105.94
Investing-8.6-51.27158.3558.42
Financing126.445.3445.491.15

About C4

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

C4 Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$3.38
$2.50
-26.07%
Oct 2026
$3.35
$3.38
+1.35%
Sep 2026
$3.69
$3.33
-18.58%
Aug 2026
$3.46
$4.09
+17.19%
Jul 2026
$4.71
$3.49
-24.95%
Jun 2026
$4.34
$4.65
+5.92%
May 2026
$2.77
$4.39
+55.12%
Apr 2026
$2.67
$2.83
+7.60%
Mar 2026
$2.63
$2.63
-2.77%
Feb 2026
$1.89
$2.71
+43.12%
Jan 2026
$1.97
$1.89
-1.05%
Dec 2025
$2.60
$1.91
-29.26%

C4 Share Price FAQs